O’Brien Research Group

Provocative health policy research in urology. Non-profit. #ORG

[O’Brien Research Group @OBrienRsrchGrp]

@kdpsinghlab @VickersBiostats Thank you!

[O’Brien Research Group @OBrienRsrchGrp]

@AustenSlade HoLEP reimburses poorly, disincentivizing investment of time into the learning curve. https://t.co/7IHNtgG5oP

[O’Brien Research Group @OBrienRsrchGrp]

@DrCraigles @OHSUurology Xandrogen

[O’Brien Research Group @OBrienRsrchGrp]

We’re celebrating our 2nd year anniversary!!! Throw back to our first ORG research meeting over beers and King burritos 5/25/2019!! 🥳

[JAMA Network Open @JAMANetworkOpen]

In a real-world setting, patients with metastatic ccRCC who received first-line immunotherapy or combination immuno/targeted therapy had improved OS compared to those who received first-line targeted therapy alone. https://t.co/pWnAvVqLr9

[O’Brien Research Group @OBrienRsrchGrp]

@DavidJiangMD

[O’Brien Research Group @OBrienRsrchGrp]

@KamranSajadi @DavidJiangMD

[O’Brien Research Group @OBrienRsrchGrp]

@DavidJiangMD @YSL_MD @RDFisherMD @UCSD_Urology Yikes. If that’s the case hopefully his program pays for the rental.

[O’Brien Research Group @OBrienRsrchGrp]

@KeiMD @RyanWerntzMD @VigneshPackiam @UofSCSOMG @OHSUurology @donsickmun @KyleGillis5 @DavidJiangMD @SarahHechtMD @AmlingC Busting urologic myths! Can you put saline in a foley ballon? Does urojet work? Is mannitol a free radical scavenging junkyard dog?

[O’Brien Research Group @OBrienRsrchGrp]

@RyanWerntzMD @KeiMD @VigneshPackiam @UofSCSOMG @OHSUurology @donsickmun @KyleGillis5 @DavidJiangMD @SarahHechtMD @AmlingC Actually everyone agreed it was the best grand rounds of all time. The illustrious ORG repeated it last year. Should be a GME requirement.

[O’Brien Research Group @OBrienRsrchGrp]

@DavidJiangMD @wsbmod 💎✊

[O’Brien Research Group @OBrienRsrchGrp]

@KamranSajadi He apparently wrote the song in ten minutes and recorded it in a single take. https://t.co/4m2riNZQtv

[European Urology @EUplatinum]

January 2021 Issue
Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors
https://t.co/g7sDrR2jN3

[UroToday.com @urotoday]

#SUO20 #Debate: Neoadjuvant vs. Adjuvant Chemotherapy for #UTUC. Neoadjuvant presentation by Jen-Jane Liu, MD @OHSUurology. Written coverage by @GoldbergHanan @UrologyUpstate on UroToday > https://t.co/JCkSVCanEZ @UroOnc @SUO_YUO

[Angie Smith @angiesmith_uro]

Excellent debate led by @siadaneshmand b/w neaodjuvant vs adjuvant chemo for #utuc by @JJLiuMD & our very own @UNCUroOnc super ⭐️ @TracyLRoseMD

Like bladder, will be about selecting who benefits most from NAC, avoiding overttreatment #suo20

[Global Society of Rare Genitourinary Tumors @GTumors]

Proud of our superstar fellow Dr Nick Chakiryan and his presented podium at virtual SUO 2020. Highly actionable results ie primary tumor stage drives nodal upstaging. @MoffittGUOnc @AndreaNecchi @SpiessPhilippe @SUO_YUO

[UroToday.com @urotoday]

Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 #Penile squamous cell carcinoma. Presented by Nicholas Chakiryan, MD @MoffittNews. #SUO20 written coverage by @zklaassen_md @GACancerCenter > https://t.co/1fFZvSwNMV @UroOnc @SUO_YUO

[OHSU Urology Residents @OHSUUroRes]

We wish our applicants could be here in person to interview on this beautiful Portland day! Looking forward to meeting you all today!